Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Cardiovasc. Med.

Sec. Cardiovascular Pharmacology and Drug Discovery

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1492499

This article is part of the Research TopicCommunity Series in New Mechanisms and Drugs for the Treatment of Cardiovascular Disease with Diabetes: Vol. IIView all 3 articles

The Role of Nrf2 Signaling Pathway in Diabetic Cardiomyopathy: From Pathogenesis to Traditional Chinese Medicine Intervention

Provisionally accepted
Huixian  GuHuixian Gu1Junchang  LiuJunchang Liu1Jiang  JieJiang Jie1Hongyan  MaHongyan Ma1Siyu  WuSiyu Wu1Longfei  SunLongfei Sun2*Lan  YaoLan Yao1*
  • 1Xinjiang Medical University, Urumqi, China
  • 2Hospital of Traditional Chinese Medicine of Xinjiang Uygur Autonomous Region, Urumqi, China

The final, formatted version of the article will be published soon.

Diabetic cardiomyopathy (DCM), a common diabetic complication independent of hypertension, coronary heart disease and heart valve disease is a major cause of cardiovascular mortality. The pathogenesis of DCM is complex. The Nrf2-related signaling pathway which regulates oxidative stress, energy metabolism and mitochondrial physiology may play important role in the pathogenesis of DCM. Current treatments for DCM focus on blood glucose and pressure control, cardiovascular protection, lipid lowering and blockade of the renin-angiotensin system. However, the adverse drug reactions are inevitable. Traditional Chinese medicine (TCM) as a multi-target, multi-pathway treatment approach is considered to be a promising therapy for DCM. We reviewed how the Nrf2 and related signaling pathway regulated pathophysiological processes such as oxidative stress, inflammation, myocardial fibrosis, apoptosis, ferroptosis, autophagy and mitochondrial dysfunction in the progression of DCM and explored the potential mechanism and clinical value of TCM in DCM treatment. Based on a literature review, we found that various herbal compounds and combinations could alleviate DCM via the Nrf2 signaling pathway. This review highlighted the role of the Nrf2 signaling pathway in DCM progression and put forwarded new therapeutic strategies for DCM.

Keywords: Nrf2 signaling pathway, Diabetic cardiomyopathy, Pathogenesis, Traditional Chinese Medicine, Therapeutic mechanism

Received: 07 Sep 2024; Accepted: 26 Jun 2025.

Copyright: © 2025 Gu, Liu, Jie, Ma, Wu, Sun and Yao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Longfei Sun, Hospital of Traditional Chinese Medicine of Xinjiang Uygur Autonomous Region, Urumqi, China
Lan Yao, Xinjiang Medical University, Urumqi, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.